1
|
Galea LA, Hildebrand MS, Witkowski T, Joy C, McEvoy CR, Hanegbi U, Aga A. ALK-rearranged renal cell carcinoma with TPM3::ALK gene fusion and review of the literature. Virchows Arch 2023; 482:625-633. [PMID: 36370168 DOI: 10.1007/s00428-022-03451-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2022] [Revised: 10/11/2022] [Accepted: 11/04/2022] [Indexed: 11/13/2022]
Abstract
ALK-rearranged renal cell carcinoma (ALK-RCC) is a very rare novel molecularly defined entity in the recently published fifth edition of the World Health Organization classification of tumours. We describe a case of ALK-RCC in a 76-year-old female. The tumour was composed of discohesive rhabdoid cells and pleomorphic, multinucleated cells (equivalent to ISUP/WHO grade 4). The tumour showed expression with PAX8, Keratin 7 and alpha methylacyl CoA racemase. ALK (D5F3 clone) was strongly and diffusely positive. ALK-FISH showed significant split signals of ALK, confirming the diagnosis. RNA sequencing showed TPM3::ALK rearrangement. Including the current case, there are 14 reported ALK-RCC cases with the same TPM3 fusion partner gene. Review of these published cases highlights their morphological heterogeneity and stresses the importance of running ALK immunohistochemistry on difficult cases to classify renal tumours. This is important while identification of ALK-RCC has clinical significance due to the availability of targeted therapy with ALK inhibitors.
Collapse
Affiliation(s)
- Laurence A Galea
- Department of Anatomical Pathology, Melbourne Pathology, Sonic Healthcare, Private Bag 5, Collingwood, VIC, 3066, Australia.
| | - Michael S Hildebrand
- Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Melbourne, VIC, Australia
- Neuroscience Group, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, Australia
| | - Tom Witkowski
- Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Melbourne, VIC, Australia
| | - Christopher Joy
- Department of Cytogenetics, Sullivan Nicolaides Pathology, Sonic Healthcare, Brisbane, QLD, Australia
| | - Christopher R McEvoy
- Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
| | - Uri Hanegbi
- Australian Urology Associates, Malvern, Melbourne, VIC, Australia
- Cabrini Hospital, Melbourne, VIC, Australia
| | - Ahmad Aga
- Department of Anatomical Pathology, Cabrini Pathology, Sonic Healthcare, Melbourne, VIC, Australia
| |
Collapse
|
2
|
Chow K, Bedő J, Ryan A, Agarwal D, Bolton D, Chan Y, Dundee P, Frydenberg M, Furrer MA, Goad J, Gyomber D, Hanegbi U, Harewood L, King D, Lamb AD, Lawrentschuk N, Liodakis P, Moon D, Murphy DG, Peters JS, Ruljancich P, Verrill CL, Webb D, Wong LM, Zargar H, Costello AJ, Papenfuss AT, Hovens CM, Corcoran NM. Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival. Eur J Cancer 2021; 148:440-450. [PMID: 33678516 DOI: 10.1016/j.ejca.2020.12.030] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2020] [Revised: 12/09/2020] [Accepted: 12/19/2020] [Indexed: 12/26/2022]
Abstract
BACKGROUND Ductal adenocarcinoma is an uncommon prostate cancer variant. Previous studies suggest that ductal variant histology may be associated with worse clinical outcomes, but these are difficult to interpret. To address this, we performed an international, multi-institutional study to describe the characteristics of ductal adenocarcinoma, particularly focussing on the effect of presence of ductal variant cancer on metastasis-free survival. METHODS Patients with ductal variant histology from two institutional databases who underwent radical prostatectomies were identified and compared with an independent acinar adenocarcinoma cohort. After propensity score matching, the effect of the presence of ductal adenocarcinoma on time to biochemical recurrence, initiation of salvage therapy and the development of metastatic disease was determined. Deep whole-exome sequencing was performed for selected cases (n = 8). RESULTS A total of 202 ductal adenocarcinoma and 2037 acinar adenocarcinoma cases were analysed. Survival analysis after matching demonstrated that patients with ductal variant histology had shorter salvage-free survival (8.1 versus 22.0 months, p = 0.03) and metastasis-free survival (6.7 versus 78.6 months, p < 0.0001). Ductal variant histology was consistently associated with RB1 loss, as well as copy number gains in TAP1, SLC4A2 and EHHADH. CONCLUSIONS The presence of any ductal variant adenocarcinoma at the time of prostatectomy portends a worse clinical outcome than pure acinar cancers, with significantly shorter times to initiation of salvage therapies and the onset of metastatic disease. These features appear to be driven by uncoupling of chromosomal duplication from cell division, resulting in widespread copy number aberration with specific gain of genes implicated in treatment resistance.
Collapse
Affiliation(s)
- Ken Chow
- Department of Surgery, University of Melbourne, Parkville, Victoria, Australia; Urology Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia.
| | - Justin Bedő
- Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia; Department of Computing and Information Systems, University of Melbourne, Melbourne, Victoria, Australia
| | - Andrew Ryan
- TissuPath Specialist Pathology, Mount Waverley, Victoria, Australia
| | - Dinesh Agarwal
- Urology Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia; Department of Urology, Western Health, Footscray, Victoria, Australia
| | - Damien Bolton
- Department of Urology, Austin Health, Heidelberg, Victoria, Australia
| | - Yee Chan
- Department of Urology, Austin Health, Heidelberg, Victoria, Australia
| | - Philip Dundee
- Department of Surgery, University of Melbourne, Parkville, Victoria, Australia; Urology Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia; Department of Urology, Western Health, Footscray, Victoria, Australia
| | - Mark Frydenberg
- Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia; Cabrini Institute, Cabrini Health, Malvern, Victoria, Australia
| | - Marc A Furrer
- Urology Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia; Department of Urology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Jeremy Goad
- Genitourinary Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Department of Urology, St Vincent's Health, Fitzroy, Victoria, Australia
| | - Dennis Gyomber
- Department of Urology, Austin Health, Heidelberg, Victoria, Australia
| | - Uri Hanegbi
- Department of Urology, Alfred Health, Melbourne, Victoria, Australia
| | - Laurence Harewood
- Department of Surgery, University of Melbourne, Parkville, Victoria, Australia; Urology Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia
| | - Dennis King
- Department of Urology, Alfred Health, Melbourne, Victoria, Australia
| | - Alastair D Lamb
- Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom
| | - Nathan Lawrentschuk
- Urology Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia; Department of Urology, Austin Health, Heidelberg, Victoria, Australia; Genitourinary Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
| | - Peter Liodakis
- Department of Urology, Austin Health, Heidelberg, Victoria, Australia
| | - Daniel Moon
- Department of Surgery, University of Melbourne, Parkville, Victoria, Australia; Urology Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia; Genitourinary Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
| | - Declan G Murphy
- Genitourinary Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
| | - Justin S Peters
- Urology Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia
| | | | - Clare L Verrill
- Department of Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
| | - David Webb
- Department of Urology, Austin Health, Heidelberg, Victoria, Australia
| | - Lih-Ming Wong
- Department of Surgery, University of Melbourne, Parkville, Victoria, Australia; Department of Urology, Austin Health, Heidelberg, Victoria, Australia; Department of Urology, St Vincent's Health, Fitzroy, Victoria, Australia
| | - Homayoun Zargar
- Department of Surgery, University of Melbourne, Parkville, Victoria, Australia; Urology Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia; Department of Urology, Western Health, Footscray, Victoria, Australia
| | - Anthony J Costello
- Department of Surgery, University of Melbourne, Parkville, Victoria, Australia; Urology Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia; Australian Prostate Centre, North Melbourne, Victoria, Australia
| | - Anthony T Papenfuss
- Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia; Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia; School of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia
| | - Christopher M Hovens
- Department of Surgery, University of Melbourne, Parkville, Victoria, Australia; Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia
| | - Niall M Corcoran
- Department of Surgery, University of Melbourne, Parkville, Victoria, Australia; Urology Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia; Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia; Department of Urology, Frankston Hospital, Frankston, Victoria, Australia
| |
Collapse
|
3
|
Abstract
BACKGROUND Recurrent urinary tract infections (rUTIs) and recurrent cystitis symptoms without infection occur commonly in women and present frequently in general practice. OBJECTIVE The aim of this article is to provide a management approach to the assessment and treatment of recurrent cystitis symptoms in women with rUTIs as well as women who have negative urine cultures. DISCUSSION Five common clinical scenarios are discussed with different approaches to treatment: true rUTIs with positive urine cultures, women with variable urine cultures (some positive and some negative), women with negative urine cultures who have pyuria +/- haematuria, women with completely normal urine cultures and women with ongoing symptoms after a definite UTI. Red flags signalling the need for early referral to a urologist for further assessment are discussed. Both non-antibiotic and antibiotic-related strategies to treat women with rUTIs are available.
Collapse
Affiliation(s)
- Karen McKertich
- MBBS, FRACS (Urol), Urological Surgeon, Australian Urology Associates, Vic; Cabrini Health, Vic; The Alfred Hospital, Vic
| | - Uri Hanegbi
- MBBS (Hons), FRACS (Urol), Urological Surgeon, Australian Urology Associates, Vic; Cabrini Health, Vic; The Alfred Hospital, Vic
| |
Collapse
|
4
|
Tan JL, Papa N, Hanegbi U, Snow R, Grummet J, Mann S, Cuthbertson A, Frydenberg M, Moon D. Predictors of erectile dysfunction after transperineal template prostate biopsy. Investig Clin Urol 2021; 62:159-165. [PMID: 33660442 PMCID: PMC7940858 DOI: 10.4111/icu.20200236] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2020] [Revised: 08/19/2020] [Accepted: 10/06/2020] [Indexed: 01/08/2023] Open
Abstract
Purpose To investigate the incidence and possible contributing factors of erectile dysfunction (ED) after transperineal template prostate biopsy (TTPB). Materials and Methods Males undergoing TTPB were prospectively administered a Sexual Health Inventory for Men (SHIM) questionnaire before biopsy and one month after. SHIM questionnaires were repeated at 3- and 9-months for males not receiving interventional treatment. Sexually inactive males were excluded. Interval change in SHIM categories based upon baseline characteristics were evaluated. Multivariable logistic regression models were used to evaluate predictors of change in SHIM score category. Results A total of 576 males were included in our sample. Of these, 450 (78%) males underwent their first biopsy. A decline in SHIM category within the immediate 4-weeks post-biopsy was reported by 167 males (31% of total eligible sample). Age was the strongest predictor of decline in SHIM category, the predicted probability of a decline in SHIM at age 50 was 10% (95% confidence interval [CI], 1%–19%), 32% at age 60 (95% CI, 25%–40%) and 36% at age 70 (95% CI, 29%–44%). For new onset ED, the predicted probability of ED within 4-weeks post-TTPB were 6.7% at age 50 (95% CI, 0%–15%), 26% at age 60 (95% CI, 17%–34%) and 31% at age 70 (95% CI, 21%–40%). Conclusions Older age at biopsy is an independent predictor of immediate ED after TTPB in sexually active males. This association was observed in the subgroup with no pre-existing ED. These findings provide useful information when counselling males undergoing TTPB.
Collapse
Affiliation(s)
- Jo Lynn Tan
- Department of Urology, St. Vincent's Hospital Melbourne, Victoria, Australia.
| | - Nathan Papa
- School of Public Health and Preventive Medicine, Monash University, Victoria, Australia
| | - Uri Hanegbi
- Australian Urology Associates, Malvern, Victoria, Australia
| | - Ross Snow
- Australian Urology Associates, Malvern, Victoria, Australia
| | - Jeremy Grummet
- Australian Urology Associates, Malvern, Victoria, Australia.,Department of Urology, Epworth Healthcare, Melbourne, Victoria, Australia
| | - Sarah Mann
- Department of Urology, Epworth Healthcare, Melbourne, Victoria, Australia
| | | | - Mark Frydenberg
- School of Public Health and Preventive Medicine, Monash University, Victoria, Australia.,Australian Urology Associates, Malvern, Victoria, Australia.,Department of Urology, Epworth Healthcare, Melbourne, Victoria, Australia
| | - Daniel Moon
- Australian Urology Associates, Malvern, Victoria, Australia.,Department of Urology, Epworth Healthcare, Melbourne, Victoria, Australia.,Department of Surgery, University of Melbourne, Victoria, Australia
| |
Collapse
|
5
|
Tan JL, Kalapara A, Papa N, Hanegbi U, Snow R, Grummet J, Mann S, Cuthbertson A, Frydenberg M, Moon D. Predictors of erectile dysfunction after transperineal template prostate biopsy. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33786-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
6
|
Chow* K, Ryan A, Agarwal D, Bolton D, Chan Y, Dundee P, Frydenberg M, Furrer M, Goad J, Gyomber D, Hanegbi U, Harewood L, King D, Lawrentschuk N, Lamb A, Liodakis P, Moon D, Murphy D, Peters J, Ruljancich P, Verrill C, Webb D, Wong LM, Zargar H, Costello A, Hovens C, Corcoran N. MP64-09 DUCTAL ADENOCARCINOMA OF THE PROSTATE IS ASSOCIATED WITH SHORTER METASTASIS-FREE SURVIVAL. J Urol 2020. [DOI: 10.1097/ju.0000000000000939.09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
7
|
Grummet J, Miller R, Frydenberg M, Snow R, Hanegbi U, Landau A, Moon D, Mann S, Begashaw K, O'Sullivan R, Ryan A. MP17-10 NEO ACTIVE SURVEILLANCE FOR PATIENTS WITH NEGATIVE UPFRONT PROSTATE MRI. J Urol 2018. [DOI: 10.1016/j.juro.2018.02.565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
8
|
Yao HHI, Esser M, Grummet J, Atkins C, Royce P, Hanegbi U. Lower risk of pelvic metalware infection with operative repair of concurrent bladder rupture. ANZ J Surg 2017; 88:560-564. [PMID: 29124851 DOI: 10.1111/ans.14233] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2016] [Revised: 07/22/2017] [Accepted: 08/15/2017] [Indexed: 12/01/2022]
Abstract
BACKGROUND Patients with traumatic bladder rupture frequently have associated pelvic fracture. With increasing numbers of pelvic fractures fixed internally, there are concerns that conservative management of bladder rupture may increase the risk of pelvic metalware infection. This study aims to determine if operative repair of bladder rupture in comparison to conservative management with catheter drainage alone is associated with a lower rate of infection of internal fixation device for concurrent pelvic fracture. METHODS This is a retrospective cohort study of level IV evidence. From July 2001 through June 2013, 45 multi-trauma patients at a level 1 trauma centre were identified to have sustained bladder rupture with concurrent pelvic fracture requiring internal fixation. Clinicopathological data were extracted from the TraumaNET database, medical records and health-coding database. Patients were stratified into two retrospective cohorts, management with surgical repair and management with catheter drainage alone. Fischer's exact test was used to determine whether the rate of pelvic metalware infection was different in the two cohorts. RESULTS Of the 45 patients, 13 had intraperitoneal bladder rupture, 28 had extraperitoneal bladder rupture and four had combined intra-extraperitoneal bladder rupture. The median age for this cohort was 31. Bladder rupture was surgically repaired in 36 patients and managed conservatively with catheter drainage in nine patients. The rate of pelvic internal fixation device infection was lower in patients managed with surgical repair compared with conservative management (5.6% versus 33.3%, P = 0.047). CONCLUSION Operative repair of bladder rupture is associated with a lower rate of pelvic orthopaedic hardware infection in the presence of concurrent pelvic fracture requiring internal fixation.
Collapse
Affiliation(s)
- Henry H-I Yao
- Department of Urology, The Alfred Hospital, Melbourne, Victoria, Australia
| | - Max Esser
- Department of Orthopedic Surgery, The Alfred Hospital, Melbourne, Victoria, Australia
| | - Jeremy Grummet
- Department of Urology, The Alfred Hospital, Melbourne, Victoria, Australia
| | - Chris Atkins
- Trauma Service, The Alfred Hospital, Melbourne, Victoria, Australia
| | - Peter Royce
- Department of Urology, The Alfred Hospital, Melbourne, Victoria, Australia
| | - Uri Hanegbi
- Department of Urology, The Alfred Hospital, Melbourne, Victoria, Australia
| |
Collapse
|
9
|
Tan JL, Frydenberg M, Grummet J, Hanegbi U, Snow R, Mann S, Begashaw K, Moon D. Comparison of perioperative, renal and oncologic outcomes in robotic-assisted versus open partial nephrectomy. ANZ J Surg 2017; 88:E194-E199. [DOI: 10.1111/ans.14154] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2017] [Revised: 06/14/2017] [Accepted: 06/21/2017] [Indexed: 01/20/2023]
Affiliation(s)
- Jo-Lynn Tan
- School of Medicine; The University of Western Australia; Perth Western Australia Australia
| | - Mark Frydenberg
- Department of Urology; Cabrini Healthcare; Melbourne Victoria Australia
- Australian Urology Associates; Melbourne Victoria Australia
- Department of Surgery, Central Clinical School; Monash University; Melbourne Victoria Australia
| | - Jeremy Grummet
- Department of Urology; Cabrini Healthcare; Melbourne Victoria Australia
- Australian Urology Associates; Melbourne Victoria Australia
- Department of Surgery, Central Clinical School; Monash University; Melbourne Victoria Australia
- Department of Urology; Epworth Healthcare Richmond; Melbourne Victoria Australia
| | - Uri Hanegbi
- Department of Urology; Cabrini Healthcare; Melbourne Victoria Australia
- Australian Urology Associates; Melbourne Victoria Australia
| | - Ross Snow
- Department of Urology; Cabrini Healthcare; Melbourne Victoria Australia
- Australian Urology Associates; Melbourne Victoria Australia
- Department of Urology; Epworth Healthcare Richmond; Melbourne Victoria Australia
| | - Sarah Mann
- Department of Urology; Cabrini Healthcare; Melbourne Victoria Australia
- Australian Urology Associates; Melbourne Victoria Australia
| | | | - Daniel Moon
- Department of Urology; Cabrini Healthcare; Melbourne Victoria Australia
- Australian Urology Associates; Melbourne Victoria Australia
- Department of Surgery, Central Clinical School; Monash University; Melbourne Victoria Australia
- Department of Urology; Epworth Healthcare Richmond; Melbourne Victoria Australia
- Division of Cancer Surgery; Peter MacCallum Cancer Centre; Melbourne Victoria Australia
| |
Collapse
|
10
|
Pepdjonovic L, Huang S, Dat A, Mann S, Frydenberg M, Moon D, Snow R, Hanegbi U, Landau A, O'Sullivan R, Ryan A, Grummet J. MP38-02 BIPARAMETRIC MRI: COULD IT REDUCE THE COST OF MRI WHILE MAINTAINING DIAGNOSTIC ACCURACY FOR PROSTATE CANCER? J Urol 2017. [DOI: 10.1016/j.juro.2017.02.1155] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
11
|
Pepdjonovic L, Tan GH, Huang S, Mann S, Frydenberg M, Moon D, Hanegbi U, Landau A, Snow R, Grummet J. Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis. World J Urol 2016; 35:1199-1203. [DOI: 10.1007/s00345-016-1985-1] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2016] [Accepted: 12/02/2016] [Indexed: 12/29/2022] Open
|
12
|
Huang S, Tan GH, Mann S, Ong WL, Landau A, Snow R, Hanegbi U, Moon D, Frydenberg M, Grummet J. MP53-18 ZERO SEPSIS IN 608 CONSECUTIVE TRANSPERINEAL PROSTATE BIOPSIES. J Urol 2016. [DOI: 10.1016/j.juro.2016.02.515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
13
|
Dat A, Yip CL, Hanegbi U. Beware of the 'Ascites' Patient: Delayed Presentation of Traumatic Intraperitoneal Bladder Rupture. Urol Case Rep 2015; 4:11-3. [PMID: 26793566 PMCID: PMC4719910 DOI: 10.1016/j.eucr.2015.10.012] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2015] [Revised: 10/22/2015] [Accepted: 10/26/2015] [Indexed: 11/19/2022] Open
Abstract
Delayed diagnosis of an intraperitoneal bladder rupture is rare in the post CT era. We present a case of a middle aged male with a delayed presentation of a traumatic intraperitoneal bladder rupture. He initially presented with an acute distended abdomen and acute kidney injury after an alleged assault. He was initially admitted for investigation of his ‘ascites.’ This case to our knowledge is the longest delay to diagnosis (>2 weeks) for an intraperitoneal bladder rupture in the post computed tomography era and should serve as a learning point in the workup of the patient with suspected blunt bladder injury.
Collapse
Affiliation(s)
- Anthony Dat
- Department of Urology, Alfred Hospital, Melbourne, Victoria 3004, Australia
| | - Chew Lin Yip
- Department of Urology, Alfred Hospital, Melbourne, Victoria 3004, Australia
| | - Uri Hanegbi
- Department of Urology, Alfred Hospital, Melbourne, Victoria 3004, Australia
| |
Collapse
|
14
|
|